Back to top
more

Elevance Health, Inc. (ELV)

(Delayed Data from NYSE)

$533.73 USD

533.73
916,012

+0.81 (0.15%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $533.76 +0.03 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical Services

Better trading starts here.

Balance Sheet

Research for ELV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Elevance Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 36,369 34,292 33,028 30,733 25,988
Receivables 17,865 16,044 13,440 10,958 10,553
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 5,795 5,281 4,654 4,060 2,492
Total Current Assets 60,029 55,617 51,122 45,751 39,033
Net Property & Equipment 4,359 4,316 3,919 3,483 3,133
Investments & Advances 6,983 6,437 5,857 4,847 4,763
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 35,590 34,698 34,843 31,096 29,174
Deposits & Other Assets 1,967 1,704 1,719 1,438 1,350
Total Assets 108,928 102,772 97,460 86,615 77,453
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 225 265 275 0 1,051
Accounts Payable 23,021 21,203 18,488 16,852 13,209
Current Portion Long-Term Debt 1,649 1,500 1,599 700 1,598
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 16,896 16,728 14,523 11,901 7,759
Total Current Liabilities 41,791 39,696 34,885 29,453 23,617
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1,970 2,034 2,805 2,019 2,227
Convertible Debt 0 0 0 0 0
Long-Term Debt 23,246 22,349 21,157 19,335 17,787
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2,516 2,299 2,485 2,609 2,094
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 69,523 66,378 61,332 53,416 45,725
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 3 3
Capital Surplus 8,868 9,084 9,148 9,244 9,448
Retained Earnings 31,749 29,724 27,088 23,802 22,573
Other Equity -1,214 -2,416 -110 150 -296
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 39,405 36,394 36,128 33,199 31,728
Total Liabilities & Shareholder's Equity 108,928 102,772 97,460 86,615 77,453
Total Common Equity 39,405 36,394 36,128 33,199 31,728
Shares Outstanding 233.00 240.00 242.70 248.70 253.50
Book Value Per Share 169.12 151.64 148.86 133.49 125.16

Fiscal Year End for Elevance Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 36,267 36,369 38,895 38,284 38,170
Receivables 18,293 17,865 16,932 16,523 16,710
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 6,388 5,795 5,358 4,936 4,943
Total Current Assets 60,948 60,029 61,185 59,743 59,823
Net Property & Equipment 4,451 4,359 4,248 4,547 4,418
Investments & Advances 7,593 6,983 6,934 6,768 6,754
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 36,657 35,590 35,782 35,977 36,188
Deposits & Other Assets 2,245 1,967 2,329 2,133 1,857
Total Assets 111,894 108,928 110,478 109,168 109,040
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 1,575 225 0 265 265
Accounts Payable 22,117 23,021 22,159 21,198 20,601
Current Portion Long-Term Debt 2,900 1,649 799 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 17,742 16,896 20,379 20,108 21,023
Total Current Liabilities 44,334 41,791 43,337 41,571 41,889
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2,201 1,970 1,779 1,852 2,029
Convertible Debt 0 0 0 0 0
Long-Term Debt 21,976 23,246 24,045 24,859 25,201
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2,673 2,778 2,574 2,461
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 71,184 69,523 71,939 70,856 71,580
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 8,883 8,868 8,830 8,761 8,697
Retained Earnings 33,088 31,749 32,103 31,608 30,707
Other Equity -1,263 -1,214 -2,396 -2,059 -1,946
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 40,710 39,405 38,539 38,312 37,460
Total Liabilities & Shareholder's Equity 111,894 108,928 110,478 109,168 109,040
Total Common Equity 40,710 39,405 38,539 38,312 37,460
Shares Outstanding 232.40 233.00 234.90 235.60 237.00
Book Value Per Share 175.17 169.12 164.07 162.61 158.06